Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human genomic DNA is the entirety of the hereditary material found in human cells, consisting of approximately 3.1 billion base pairs of deoxyribonucleic acid (DNA), packaged into 23 chromosome pairs in the nucleus and also a separate, much smaller mitochondrial genome[3][5]. It contains regions coding for proteins (~1-2% of the genome), non-coding functional elements such as regulatory sequences and non-coding RNAs, as well as large amounts of non-coding, sometimes repetitive DNA, including introns, structural DNA (telomeres, centromeres), transposons, and pseudogenes[1][2][5]. Human genomic DNA serves as the template for all genetic information transfer, controls cell function, and is essential for reproduction and development. Because "Human genomic DNA" refers to the entire genome rather than a specific, actionable molecular target (like a receptor, enzyme, or single gene), it is not considered a therapeutic target in itself[5], but is the subject of analysis in genomics, diagnostics, forensics, and genetic engineering.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human genomic DNA.